Research and Outcomes

Stroke research is a vital component for patients at Cedars-Sinai's Stroke Program. Director Patrick D. Lyden, MD and the Stroke Program's staff are currently involved in National Institutes of Health (NIH) funded clinical trials relating to stroke prevention, acute stroke therapy and neuroimaging in stroke.Because of their active participation in these and other clinical stroke research trials, the Stroke Program team is able to develop effective treatment options for stroke patients.

The Cedars-Sinai Stroke Program is currently partnering with the Cedars-Sinai Neurovascular Center on clinical trials, as well as working with The Field Administration of Stroke Therapy.

Click here to go to the clinical trials database for more information (in the search box type "stroke"). Current studies include:

  • CLEAR-III
  • FAST-MAG
  • GORE-REDUCE Study
  • Insulin resistance intervention after stroke trial
  • Interventional imaging in cerebral blood volume study in patients with acute stroke
  • Penumbra imaging collaborative study (PICS): A Multicenter Trial to Assess Outcomes of Patients Revascularized by the Penumbra System
  • Performance of "SmartRisk" Prediction of stroke and stroke-related events in carotid atherosclerosis
  • ResStore medical device trial for acute stroke revascularization
  • SAMMPRIS: Preventing Recurrent Stroke in Patients with Intracranial Stenosis, Stenting and Aggressive Medical Management
  • SAPPHIRE: Less invasive carotid stenting procedures for patients at high risk for surgery for blockages of carotid artery
  • The Field Administration of Stroke Therapy: Magnesium Phase 3 Clinical Trial (FAST-Mag)
  • The THERAPY trial

Clinical Trials National Directory

 

For an appointment, a second opinion or more information, please call 1-800-CEDARS-1 (1-800-233-2771) or email us at neurologicaldisorders@cshs.org.